US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

223.00

-4.7500-2.09%

Pre-market: 225.662.66+1.19%08:40 EDT

Volume:804.93K

Turnover:174.45M

Market Cap:585.26M

PE:- -

High:224.85

Open:221.88

Low:208.28

Close:227.75

52wk High:341.93

52wk Low:102.35

Shares:2.62M

Float Shares:2.62M

Volume Ratio:1.53

T/O Rate:30.67%

Dividend:0.91

Dividend Rate:0.41%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Fidia’s August 2026 figures show tight liquidity under CONSOB’s enhanced disclosure regime

Health Care Roundup: Market Talk

Autagco Signs Non-Binding MOU to Drive Healthcare and Wellness Expansion

Jefferies Remains a Buy on Humana (HUM)

Trump Pledges $500 Rebates to 1 Million Medicare Beneficiaries Each, to Be Mailed Starting Oct. 1

Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA) and Immunome (IMNM)

Is Ping An Healthcare And Technology (SEHK:1833) Undervalued After Its GlobalCare Launch?

Simply Wall St.

LIVE Markets-TD Cowen Says AI Promises Hospitals a Margin Cure

Pharming Group: Buy Rating Maintained and Strategy Intact Despite Surprise CEO Departure; Price Target Reaffirmed at $38

LIVE Markets-Cooler than Expected PCE Adds Some Steam to US Stock Futures

Health Care Select Sector SPDR: Pivot points

Abbott announces U.S. commercial launch of SimpleScreen CRC

Celcuity Announces That REVTORPYK™ (gedatolisib) Is Now Commercially Available In The United States

CeriBell Receives FDA Clearance for Platform Software Update

MT Newswires Live

Tiziana Life Sciences Seeks FDA Orphan Status for Intranasal Foralumab in Multiple System Atrophy

Ceribell receives FDA 510k clearance of quantitative EEG trending, analysis

Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)

Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis

Aldeyra Therapeutics: Neutral Rating Maintained Amid FDA Uncertainty; $2 Price Target Reaffirmed

Roche’s Genentech announces FDA approves NDA for fenebrutinib

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LABU/news?page=15"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":223,"timestamp":1791489600000,"preClose":227.75,"halted":0,"volume":804929,"hourTrading":{"tag":"盘前","latestPrice":225.66,"preClose":223,"latestTime":"08:40 EDT","volume":2061,"amount":464215.18824,"timestamp":1791549657904,"change":2.66,"changeRate":0.011928,"amplitude":0.01487},"delay":0,"changeRate":-0.020856201975850714,"floatShares":2624500,"shares":2624500,"eps":0,"marketStatus":"Pre-Mkt","change":-4.75,"latestTime":"10-09 08:41:49 EDT","open":221.88,"high":224.8479,"low":208.28,"amount":174447835.0605,"amplitude":0.072746,"askPrice":226.4,"askSize":400,"bidPrice":223.58,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791552600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":223,"sharesOutstanding":3074486,"nav":227.52,"aum":597123938.28,"dividendRate":0.0041,"bidAskSpread":0.003146,"preHourTrading":{"tag":"盘前","latestPrice":225.66,"preClose":223,"latestTime":"08:40 EDT","volume":2061,"amount":464215.18824,"timestamp":1791549657904,"change":2.66,"changeRate":0.011928,"amplitude":0.01487},"postHourTrading":{"tag":"盘后","latestPrice":223.66,"preClose":223,"latestTime":"19:57 EDT","volume":4124,"amount":918785.7173,"timestamp":1791503872443,"change":0.66,"changeRate":0.00296,"amplitude":0.008427},"volumeRatio":1.526100709509335,"impliedVol":1.0277,"impliedVolPercentile":0.904},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2624500,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.526100709509335,"shares":2624500,"dividePrice":0.9143,"high":224.8479,"amplitude":0.072746,"preClose":227.75,"low":208.28,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":223,"committee":-0.333333,"eps":0,"divideRate":0.0041,"volume":804929,"delay":0,"ttmEps":0,"open":221.88,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":249.65,"twentyDayClose":266,"sixtyDayClose":277.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:15,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672786017","title":"Fidia’s August 2026 figures show tight liquidity under CONSOB’s enhanced disclosure regime","url":"https://stock-news.laohu8.com/highlight/detail?id=2672786017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672786017?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:22","pubTimestamp":1790785366,"startTime":"0","endTime":"0","summary":"Fidia Spa ( ($IT:FDA) ) just unveiled an update. Fidia S.p.A. reported its net financial position for August 2026 as part of the enhanced monthly d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fidias-august-2026-figures-show-tight-liquidity-under-consobs-enhanced-disclosure-regime?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fidias-august-2026-figures-show-tight-liquidity-under-consobs-enhanced-disclosure-regime?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VGT","BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672786420","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2672786420","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672786420?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:20","pubTimestamp":1790785200,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0508 ET - Investors are dialing up their bets on the life-scienc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","BK4585","LABU","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672863937","title":"Autagco Signs Non-Binding MOU to Drive Healthcare and Wellness Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2672863937","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672863937?lang=en_us&edition=fundamental","pubTime":"2026-09-30 23:59","pubTimestamp":1790783949,"startTime":"0","endTime":"0","summary":"The latest update is out from Autagco Ltd. ( ($SG:WNH) ). Autagco Ltd. has entered into a non-binding memorandum of understanding with CCECC Asia-P...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/autagco-signs-non-binding-mou-to-drive-healthcare-and-wellness-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/autagco-signs-non-binding-mou-to-drive-healthcare-and-wellness-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4581","BK4137","BK4585","LABU","BK4588","LU0029874061.USD","XBI","BK4209","XLV","HCSG","SG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672478680","title":"Jefferies Remains a Buy on Humana (HUM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672478680","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672478680?lang=en_us&edition=fundamental","pubTime":"2026-09-30 23:55","pubTimestamp":1790783739,"startTime":"0","endTime":"0","summary":"Jefferies analyst David Windley maintained a Buy rating on Humana today and set a price target of $420.00. Windley covers the Healthcare sector, fo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-humana-hum-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-humana-hum-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0266013472.USD","LU0238689110.USD","SG9999014013.SGD","HUM","LU0256863811.USD","IHF","LU0320765489.SGD","LABU","LU0070302665.USD","BK4581","LU0208291251.USD","BK4154","XBI","LU0390134368.USD","LU1093756325.SGD","BK4588","XLV","LU0348723411.USD","FXH","LU0417517546.SGD","BK4533","LU0211331839.USD","LU1093756168.USD","LU1983260115.SGD","BK4566","SG9999014021.USD","BK4585","LU0170899867.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671378546","title":"Trump Pledges $500 Rebates to 1 Million Medicare Beneficiaries Each, to Be Mailed Starting Oct. 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2671378546","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671378546?lang=en_us&edition=fundamental","pubTime":"2026-09-30 23:30","pubTimestamp":1790782233,"startTime":"0","endTime":"0","summary":"U.S. President Donald Trump announced that nearly 1 million Americans who purchased insurance through the federal health insurance exchange will receive a $500 rebate each. The White House stated that rebate checks will be mailed starting October 1, 2026, covering 30 states that use the federal platform.","market":"us","thumbnail":"https://resource.tradingkey.com/uploads/20251024/trump-8422d99716774d0983e2d51ad4c8b08d.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/trump-8422d99716774d0983e2d51ad4c8b08d.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262194471-trump-500-refund-health-insurance-aca-exchange-1-million-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","IYH","IHF","LNGR","XLV","UNHW","BK4585","LABU","UN","UNHG","UNHU","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671851997","title":"Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA) and Immunome (IMNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671851997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671851997?lang=en_us&edition=fundamental","pubTime":"2026-09-30 23:20","pubTimestamp":1790781616,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Kailera Therapeutics, Inc. (KLRA) and Immunome (IMNM...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kailera-therapeutics-inc-klra-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kailera-therapeutics-inc-klra-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4563","OZEM","BK4139","BK4588","IMNM","XBI","XLV","BK4137","LABU","LU0029874061.USD","BK4581","BK4585","HCSG","KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672873841","title":"Is Ping An Healthcare And Technology (SEHK:1833) Undervalued After Its GlobalCare Launch?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672873841","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672873841?lang=en_us&edition=fundamental","pubTime":"2026-09-30 22:24","pubTimestamp":1790778257,"startTime":"0","endTime":"0","summary":"Ping An Healthcare and Technology (SEHK:1833) has put its new Ping An GlobalCare platform in the spotlight by launching a trial in Shenzhen that combines AI-driven real-time medical translation with a fully coordinated online and offline care journey.\nAgainst this product launch, Ping An Healthcare and Technology’s recent share price return has been mixed, with a 7 day gain of 4.02% but a 90 day decline of 10.25% and a year to date fall of 56.48% at a HK$6.345 close. Over a longer horizon,...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/5021000-choice2-card/1789013271957","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/5021000-choice2-card/1789013271957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/is-ping-an-healthcare-and-technology-sehk1833-undervalued-af","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/is-ping-an-healthcare-and-technology-sehk1833-undervalued-af","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01833","LABU","XLV","XBI","HCSG","BK1247","BK1571","BK1515","BK1617","BK4588","BK1219","LU0128526141.USD","LU0029874061.USD","BK1615","BK4581","BK4137","BK4585","DCF","BK1142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671207594","title":"LIVE Markets-TD Cowen Says AI Promises Hospitals a Margin Cure","url":"https://stock-news.laohu8.com/highlight/detail?id=2671207594","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671207594?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:18","pubTimestamp":1790774293,"startTime":"0","endTime":"0","summary":"CLICK HEREWHAT TO THINK ABOUT IN Q4CLICK HERESTOCKS POISED FOR NEXT LEG HIGHER... IF OIL DROPSCLICK HERESTOXX SET FOR MONTHLY FALL, BUT A STEADY QUARTERCLICK HEREBEFORE THE BELL: SET TO END THE MONTH ON A HIGH NOTECLICK HEREA CRUEL QUARTER FOR BONDSCLICK HERE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL6N45M0UY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211327993.USD","LU0878866978.SGD","LU0985489474.SGD","IHF","LU0211328371.USD","IE00B775SV38.USD","LU0882574055.USD","LU0648000940.SGD","LU1267930490.SGD","LU0868494617.USD","LU1084165304.USD","BK4504","BK4588","LABU","LU0187121727.USD","LU0130102774.USD","SG9999014005.SGD","LU0708994859.HKD","BK4585","LU1201861249.SGD","UHS","LU0203345920.USD","THC","LU0128525929.USD","XBI","IE00B3S45H60.SGD","XLV","BK4185","LU1267930573.SGD","LU0310800379.SGD","LU0114720955.EUR","HCA","SG9999014039.USD","LU1489326972.SGD","LU1201861165.SGD","BK4581","LU0980610538.SGD","LU1119994496.HKD","LU1150488135.SGD","LU1150488218.USD","LU0310799852.SGD","LU1261432733.SGD","LU0068578508.USD","SG9999014021.USD","LU0433182093.SGD","LU0130103400.USD","LU0203347892.USD","LU0029864427.USD","LU2244417387.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671207668","title":"Pharming Group: Buy Rating Maintained and Strategy Intact Despite Surprise CEO Departure; Price Target Reaffirmed at $38","url":"https://stock-news.laohu8.com/highlight/detail?id=2671207668","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671207668?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:15","pubTimestamp":1790774145,"startTime":"0","endTime":"0","summary":"Pharming Group, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Whitney Ijem from Canaccord Genuity mainta...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/pharming-group-buy-rating-maintained-and-strategy-intact-despite-surprise-ceo-departure-price-target-reaffirmed-at-38-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/pharming-group-buy-rating-maintained-and-strategy-intact-despite-surprise-ceo-departure-price-target-reaffirmed-at-38-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XLV","LABU","BK4588","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671202023","title":"LIVE Markets-Cooler than Expected PCE Adds Some Steam to US Stock Futures","url":"https://stock-news.laohu8.com/highlight/detail?id=2671202023","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671202023?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:09","pubTimestamp":1790773775,"startTime":"0","endTime":"0","summary":"CLICK HEREWHAT TO THINK ABOUT IN Q4CLICK HERESTOCKS POISED FOR NEXT LEG HIGHER... IF OIL DROPSCLICK HERESTOXX SET FOR MONTHLY FALL, BUT A STEADY QUARTERCLICK HEREBEFORE THE BELL: SET TO END THE MONTH ON A HIGH NOTECLICK HEREA CRUEL QUARTER FOR BONDSCLICK HERELMData093020","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL6N45M0NX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLB","BK4535","SOXQ","KRE","LABU","BK4585","XLK","BK4581","XBI","XLV","BK4588","XLY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671047562","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2671047562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671047562?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:37","pubTimestamp":1790771845,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $172.50, Pivot Low: $169.78. These were calculated usi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-153?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-153?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","BK4585","BK4588","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671204888","title":"Abbott announces U.S. commercial launch of SimpleScreen CRC","url":"https://stock-news.laohu8.com/highlight/detail?id=2671204888","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671204888?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:06","pubTimestamp":1790769961,"startTime":"0","endTime":"0","summary":"Abbott (ABT) announced the U.S. commercial launch of SimpleScreen CRC, an FDA-approved blood-based colorectal cancer screening test for adults age ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbott-announces-u-s-commercial-launch-of-simplescreen-crc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbott-announces-u-s-commercial-launch-of-simplescreen-crc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1914381329.SGD","IHI","BK4504","LU1721429741.USD","LU2133065610.SGD","LU0211331839.USD","LU0114720955.EUR","LU0320765489.SGD","LU0456854461.SGD","LABU","TMED","LU1670627923.USD","LU2468319806.SGD","LU1023059063.AUD","LU0266013472.USD","LU0208291251.USD","ABT","CRC","LU2089984988.USD","LU1057294990.SGD","PJP","LU1691799644.USD","LU2324357040.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0882574055.USD","SG9999002224.SGD","BK4213","BK4592","LU1989763427.SGD","LU0432979614.USD","IE00B2B36J28.USD","SG9999002232.USD","LU2211815571.USD","SG9999004303.SGD","SGXZ23171101.USD","IE0002141913.USD","LU2237957811.SGD","LU1670628061.USD","LU1721429402.USD","LU2112291526.USD","LU0070302665.USD","LU0234572021.USD","BK4588","BK4581","LU0058720904.USD","BK4082","LU0266512127.USD","IE00BJT1NW94.SGD","LU1989763690.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671253201","title":"Celcuity Announces That REVTORPYK™ (gedatolisib) Is Now Commercially Available In The United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2671253201","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671253201?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:00","pubTimestamp":1790769600,"startTime":"0","endTime":"0","summary":"REVTORPYK (gedatolisib)   REVTORPYK (gedatolisib) vial and box  REVTORPYK is indicated for patients with HR+/HER2- advanced breast cancer without a PIK3CA mutation detected following progression on or","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/30/3371842/0/en/celcuity-announces-that-revtorpyk-gedatolisib-is-now-commercially-available-in-the-united-states.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRET","IDNA","BK4599","BK4203","BK4585","LU1878469433.USD","ALT","BK4588","NVIB","UBCP","BK4139","LABU","BK4225","HR","BK4211","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220950","title":"CeriBell Receives FDA Clearance for Platform Software Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220950","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671220950?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:32","pubTimestamp":1790767962,"startTime":"0","endTime":"0","summary":"CeriBell (CBLL) has received the US Food and Drug Administration's approval for a software update that will add three capabilities to its namesake platform, the company said Wednesday.The new capabili","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","BK4588","BK4585","CBLL","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671209180","title":"Tiziana Life Sciences Seeks FDA Orphan Status for Intranasal Foralumab in Multiple System Atrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2671209180","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671209180?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:28","pubTimestamp":1790767704,"startTime":"0","endTime":"0","summary":"An update from Tiziana Life Sciences ( ($TLSA) ) is now available. On September 30, 2026, Tiziana Life Sciences announced it has filed a request wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-seeks-fda-orphan-status-for-intranasal-foralumab-in-multiple-system-atrophy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-seeks-fda-orphan-status-for-intranasal-foralumab-in-multiple-system-atrophy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671209919","title":"Ceribell receives FDA 510k clearance of quantitative EEG trending, analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2671209919","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671209919?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:20","pubTimestamp":1790767236,"startTime":"0","endTime":"0","summary":"CeriBell (CBLL) announced that the U.S. Food and Drug Administration, FDA, has cleared new software for the Ceribell System that “makes it easier a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ceribell-receives-fda-510k-clearance-of-quantitative-eeg-trending-analysis-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ceribell-receives-fda-510k-clearance-of-quantitative-eeg-trending-analysis-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QQH","IGM","BK4082","BK4585","CBLL","BK4588","VGT","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671280201","title":"Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671280201","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671280201?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:00","pubTimestamp":1790766000,"startTime":"0","endTime":"0","summary":"BOSTON, Sept.  30, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq:TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/30/3371756/0/en/tiziana-life-sciences-files-for-orphan-drug-designation-with-the-fda-for-intranasal-foralumab-for-the-treatment-of-multiple-system-atrophy-msa.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1121112475.USD","LU2506951875.HKD","MSA","BK4183","LU0426417589.USD","LU1430594728.SGD","LU2506952170.USD","BK4085","LU2247934214.USD","ODD","LU0950375773.USD","LU2125909759.SGD","LABU","LU2211815571.USD","BK4577","LU2125909916.SGD","BK4585","LU1585245621.USD","BK4588","LU1043141123.HKD","LU1923622291.USD","LU1043141396.HKD","BK4533","LU0823417737.USD","LU0994945656.USD","LU0640476718.USD","BNGE","LU2506952097.USD","EA","LU1280957306.USD","NERD","LU0154245756.USD","LU0006061336.USD","ESPO","BK4143","LU0053671581.USD","BK4532","HERO","LU0426412945.USD","LU2506951958.HKD","LU1815336091.USD","LU0823417653.USD","LU0154245673.USD","LU0757428866.USD","IE0009354923.USD","LU0728928796.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220149","title":"Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220149","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671220149?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:00","pubTimestamp":1790766000,"startTime":"0","endTime":"0","summary":"New clearance to further simplify bedside EEG interpretation and enable more informed interventions for patients of all ages across multiple indicationsSUNNYVALE, Calif., Sept.  30, 2026 (GLOBE NEWSWI","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/30/3371750/0/en/ceribell-receives-fda-510-k-clearance-for-quantitative-eeg-trending-and-amplitude-integrated-eeg-analysis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL","BK4214","AMPL","LABU","BK4588","SAH","BK4082","BK4023","RA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671205590","title":"Aldeyra Therapeutics: Neutral Rating Maintained Amid FDA Uncertainty; $2 Price Target Reaffirmed","url":"https://stock-news.laohu8.com/highlight/detail?id=2671205590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671205590?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:25","pubTimestamp":1790763928,"startTime":"0","endTime":"0","summary":"Analyst Matthew Caufield of H.C. Wainwright reiterated a Hold rating on Aldeyra Therapeutics, retaining the price target of $2.00. Matthew Caufield...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/aldeyra-therapeutics-neutral-rating-maintained-amid-fda-uncertainty-2-price-target-reaffirmed-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/aldeyra-therapeutics-neutral-rating-maintained-amid-fda-uncertainty-2-price-target-reaffirmed-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALDX","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220846","title":"Roche’s Genentech announces FDA approves NDA for fenebrutinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220846","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671220846?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:50","pubTimestamp":1790761812,"startTime":"0","endTime":"0","summary":"Genentech, a member of the Roche (RHHBY) Group, announced that the U.S. FDA has accepted the company’s NDA under priority review for fenebrutinib, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roches-genentech-announces-fda-approves-nda-for-fenebrutinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roches-genentech-announces-fda-approves-nda-for-fenebrutinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","CANC","LABU","HRTS","RHHBY","03165","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":15,"totalSize":427,"code":"91000000","status":"200"}]}}